155 related articles for article (PubMed ID: 30688894)
1. A Weighted Genetic Risk Score Predicts Surgical Recurrence Independent of High-Risk Clinical Features in Dupuytren's Disease.
Riesmeijer SA; Manley OWG; Ng M; Nolte IM; Broekstra DC; Werker PMN; Furniss D
Plast Reconstr Surg; 2019 Feb; 143(2):512-518. PubMed ID: 30688894
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling and Dupuytren's disease.
Dolmans GH; Werker PM; Hennies HC; Furniss D; Festen EA; Franke L; Becker K; van der Vlies P; Wolffenbuttel BH; Tinschert S; Toliat MR; Nothnagel M; Franke A; Klopp N; Wichmann HE; Nürnberg P; Giele H; Ophoff RA; Wijmenga C; ; ; ;
N Engl J Med; 2011 Jul; 365(4):307-17. PubMed ID: 21732829
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
[TBL] [Abstract][Full Text] [Related]
4. Skin involvement in Dupuytren's disease.
Wade R; Igali L; Figus A
J Hand Surg Eur Vol; 2016 Jul; 41(6):600-8. PubMed ID: 26353945
[TBL] [Abstract][Full Text] [Related]
5. The importance of genetic susceptibility in Dupuytren's disease.
Becker K; Tinschert S; Lienert A; Bleuler PE; Staub F; Meinel A; Rößler J; Wach W; Hoffmann R; Kühnel F; Damert HG; Nick HE; Spicher R; Lenze W; Langer M; Nürnberg P; Hennies HC
Clin Genet; 2015 May; 87(5):483-7. PubMed ID: 24749973
[TBL] [Abstract][Full Text] [Related]
6. Hueston revisited: use of acellular dermal matrix following fasciectomy for the treatment of Dupuytren's disease.
Terry MJ; Sue GR; Goldberg C; Narayan D
Ann Plast Surg; 2014 Dec; 73 Suppl 2():S178-80. PubMed ID: 24691328
[TBL] [Abstract][Full Text] [Related]
7. Dupuytren's Disease Predicts Increased All-Cause and Cancer-Specific Mortality: Analysis of a Large Cohort from the U.K. Clinical Practice Research Datalink.
Kuo RYL; Ng M; Prieto-Alhambra D; Furniss D
Plast Reconstr Surg; 2020 Mar; 145(3):574e-582e. PubMed ID: 32097318
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI.
Major M; Freund MK; Burch KS; Mancuso N; Ng M; Furniss D; Pasaniuc B; Ophoff RA
Genet Epidemiol; 2019 Sep; 43(6):629-645. PubMed ID: 31087417
[TBL] [Abstract][Full Text] [Related]
9. Common variants of the EPDR1 gene and the risk of Dupuytren’s disease.
Dębniak T; Żyluk A; Puchalski P; Serrano-Fernandez P
Handchir Mikrochir Plast Chir; 2013 Oct; 45(5):253-7. PubMed ID: 24089297
[TBL] [Abstract][Full Text] [Related]
10. Is Dupuytren's disease really a 'disease of the Vikings'?
Ng M; Lawson DJ; Winney B; Furniss D
J Hand Surg Eur Vol; 2020 Mar; 45(3):273-279. PubMed ID: 31663799
[TBL] [Abstract][Full Text] [Related]
11. Risk factors in Dupuytren's diathesis: is recurrence after surgery predictable?
Degreef I; De Smet L
Acta Orthop Belg; 2011 Feb; 77(1):27-32. PubMed ID: 21473442
[TBL] [Abstract][Full Text] [Related]
12. Association of Morbus Ledderhose with Dupuytren's contracture.
Gudmundsson KG; Jónsson T; Arngrímsson R
Foot Ankle Int; 2013 Jun; 34(6):841-5. PubMed ID: 23386754
[TBL] [Abstract][Full Text] [Related]
13. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence.
Hindocha S; Stanley JK; Watson S; Bayat A
J Hand Surg Am; 2006 Dec; 31(10):1626-34. PubMed ID: 17145383
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
[TBL] [Abstract][Full Text] [Related]
15. SNPs previously associated with Dupuytren's disease replicated in a North American cohort.
Anderson ER; Ye Z; Caldwell MD; Burmester JK
Clin Med Res; 2014 Dec; 12(3-4):133-7. PubMed ID: 24573701
[TBL] [Abstract][Full Text] [Related]
16. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients.
Balaguer T; David S; Ihrai T; Cardot N; Daideri G; Lebreton E
J Hand Surg Eur Vol; 2009 Aug; 34(4):493-6. PubMed ID: 19675030
[TBL] [Abstract][Full Text] [Related]
17. Dupuytren's contracture: MR imaging findings and correlation between MR signal intensity and cellularity of lesions.
Yacoe ME; Bergman AG; Ladd AL; Hellman BH
AJR Am J Roentgenol; 1993 Apr; 160(4):813-7. PubMed ID: 8456670
[TBL] [Abstract][Full Text] [Related]
18. The relationship between body mass index and the risk of development of Dupuytren's disease: a Mendelian randomization study.
Majeed M; Wiberg A; Ng M; Holmes MV; Furniss D
J Hand Surg Eur Vol; 2021 May; 46(4):406-410. PubMed ID: 32972297
[TBL] [Abstract][Full Text] [Related]
19. Sibling recurrence risk in Dupuytren's disease.
Capstick R; Bragg T; Giele H; Furniss D
J Hand Surg Eur Vol; 2013 May; 38(4):424-9. PubMed ID: 22791609
[TBL] [Abstract][Full Text] [Related]
20. A survey of clinical manifestations and risk factors in women with Dupuytren's disease.
Degreef I; Steeno P; De Smet L
Acta Orthop Belg; 2008 Aug; 74(4):456-60. PubMed ID: 18811027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
